Brief: Equillium To Acquire Metacrine In All-Stock Transaction
06/09/2022 21:01
Sept 6 (Reuters) - Equillium Inc EQ.O :
* EQUILLIUM TO ACQUIRE METACRINE IN ALL-STOCK TRANSACTION
* EQUILLIUM INC- TRANSACTION IS ANTICIPATED TO ADD $33
MILLION IN
CASH TO EQUILLIUM'S BALANCE SHEET AT CLOSING
* EQUILLIUM INC- EXPECTED TO EXTEND COMPANY'S CASH RUNWAY
INTO
2024
* EQUILLIUM INC- WILL ISSUE STOCK VALUED AT A 25% PREMIUM
OVER NET
CASH DELIVERED AT CLOSING, WHICH IS ESTIMATED TO BE
APPROXIMATELY $26 MILLION.
Source text for Eikon: ID:nBw66Crrka
Further company coverage: EQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metacrine
See all newsMetacrine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions